Huadao Biological won the B round of ¥100 million financing led by NKY

Huadao Biological won the B round of ¥100 million financing led by NKY
Huadao Biological won the B round of ¥100 million financing led by NKY

Huadao Biological completed the B round of ¥100 million financing led by Boai NKY Medical Holdings Ltd. (SZSE:300109). This round of financing will be used for cell drug R&D and cell industrial technological innovation.

In 2017, Huadao Biology focused on drug target research and developed products including leukemia, digestive tract tumors, and other tumors.

South Africa Today

Read more at VolaNews